Updated:
Serum Institute of India
Serum Institute of India Pvt. Ltd. is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses),...
Serum Institute of India
Serum Institute of India Pvt. Ltd. is the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses), including Polio, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, Rubella, Pneumococcal and Covid-19 vaccines. About 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Its vaccines are WHO-accredited and used in around 170 countries' national immunization programs. It is ranked as India's No. 1 biotechnology company, manufacturing vaccines, antisera and other medical specialties.
General information
Firm type
other
Year founded
1966
Location
Region
North America
Country
India
City
Pune
Corporate office
Pune, Maharashtra, India
Principals
Cyrus Poonawalla
Founder
Adar Poonawalla
CEO
Sector focus
Frequently asked questions
What is the relationship between Serum Institute of India and the Poonawalla Fincorp?
Poonawalla Fincorp (formerly known as Magma Fincorp) is a non-banking financial company where the Poonawalla family holds a controlling stake, and Adar Poonawalla serves as chairman. It is a separate entity from Serum Institute of India but part of the family's broader investment portfolio.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: